{"acute coronary syndrome": 3.34, "alanine aminotransferase increased": 2.13, "anaemia": 2.56, "arteriospasm coronary": 33.24, "ascites": 3.94, "aspartate aminotransferase increased": 2.19, "ataxia": 3.34, "blood bilirubin increased": 3.51, "blood lactate dehydrogenase increased": 2.05, "blood magnesium decreased": 8.12, "blood potassium decreased": 3.03, "bone lesion": 10.61, "bone marrow failure": 2.64, "brain neoplasm": 3.69, "breast cancer": 10.13, "breast cancer metastatic": 30.75, "breast cancer recurrent": 16.08, "cardiogenic shock": 5.13, "cardiotoxicity": 37.75, "colitis": 2.22, "constipation": 2.26, "cytopenia": 3.69, "dehydration": 3.02, "diarrhoea": 4.31, "disease progression": 6.56, "drug interaction": 2.94, "drug intolerance": 3.56, "drug-induced liver injury": 6.43, "dry skin": 2.54, "ejection fraction decreased": 4.28, "electrolyte imbalance": 7.05, "enteritis": 14.38, "enterocolitis": 7.69, "febrile neutropenia": 2.69, "gastrointestinal toxicity": 31.89, "granulocyte count decreased": 12.56, "granulocytopenia": 11.84, "haematotoxicity": 11.51, "hepatic failure": 2.68, "hepatic function abnormal": 2.34, "hepatic lesion": 9.19, "hepatotoxicity": 6.05, "hiccups": 3.78, "hyperammonaemic encephalopathy": 35.76, "hyperbilirubinaemia": 7.62, "hypertransaminasaemia": 4.46, "hypokalaemia": 6.53, "hypomagnesaemia": 4.01, "hypophagia": 2.21, "ileus": 3.8, "international normalised ratio increased": 2.67, "invasive ductal breast carcinoma": 12.85, "lacrimation increased": 2.01, "laryngospasm": 13.48, "left ventricular dysfunction": 3.98, "leukopenia": 5.59, "liver disorder": 2.01, "liver injury": 3.95, "malignant neoplasm progression": 6.86, "metastases to bone": 20.42, "metastases to central nervous system": 17.55, "metastases to liver": 19.65, "metastases to lung": 13.49, "metastases to lymph nodes": 15.86, "metastases to meninges": 8.86, "metastases to peritoneum": 10.37, "metastases to skin": 33.82, "metastasis": 5.75, "metastatic neoplasm": 9.61, "mucosal inflammation": 12.36, "myelodysplastic syndrome": 3.43, "myelosuppression": 37.74, "nail disorder": 4.98, "neoplasm progression": 3.11, "neuropathy peripheral": 9.35, "neurotoxicity": 13.34, "neutropenia": 8.99, "neutrophil count decreased": 9.27, "oesophagitis": 4.42, "osteonecrosis of jaw": 2.47, "palmar-plantar erythrodysaesthesia syndrome": 25.3, "pancytopenia": 3.03, "peripheral sensory neuropathy": 7.17, "pik3ca-activated mutation": 63.31, "platelet count decreased": 7.69, "polyneuropathy": 3.34, "portal hypertension": 8.4, "posterior reversible encephalopathy syndrome": 2.74, "product use in unapproved indication": 2.93, "pulmonary mass": 3.97, "recurrent cancer": 13.9, "red blood cell count decreased": 2.51, "skin exfoliation": 2.67, "skin fissures": 11.22, "skin toxicity": 9.91, "stomatitis": 4.85, "therapy partial responder": 5.22, "thrombocytopenia": 7.73, "toxicity to various agents": 4.19, "tumour marker increased": 11.21, "venoocclusive liver disease": 8.5, "vomiting": 2.2, "white blood cell count decreased": 8.56}